Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 30, 2013Journal of Clinical GastroenterologyOpen Access

Ipilimumab-induced Perforating Colitis

View Full Paper
Ask AI
Bookmark
Share

Authors

KMKisha A. MitchellGreenwich HospitalHKHarriet M. KlugerYale Cancer CenterMSMario SznolUniversity of Toledo Medical Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Mitchell et al. (2013) studied this question.

synapsesocial.com/papers/6a787e1f137c7dcc81be7892https://doi.org/10.1097/mcg.0b013e31828f1d51
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma2011 · 4,539 citations
  2. 2Enterocolitis in Patients With Cancer After Antibody Blockade of Cytotoxic T-Lymphocyte–Associated Antigen 42006 · 837 citations
  3. 3Infliximab in the Treatment of Anti-CTLA4 Antibody (Ipilimumab) Induced Immune-Related Colitis2009 · 120 citations
  4. 4α-CTLA-4 mAb-associated Panenteritis2008 · 154 citations